CLL (Chronic Lymphocytic Leukemia),Leukemia CLL13/GAIA Trial: FCR/BR vs. RVE, GVE, and GIVE Treatment Outcomes Mar 10, 2023
CLL (Chronic Lymphocytic Leukemia),Leukemia Phase I/II Study on Mosunetuzumab's PD Biomarkers in NHL Patients Mar 10, 2023
CLL (Chronic Lymphocytic Leukemia),Leukemia Safety of Subcutaneous Mosunetuzumab in Refractory B-Cell Lymphomas: Trial Results Mar 07, 2023
CLL (Chronic Lymphocytic Leukemia),Leukemia Mosunetuzumab Shows Promise in R/R Follicular Lymphoma Treatment: Phase II Results Mar 07, 2023
CLL (Chronic Lymphocytic Leukemia),Leukemia Long-Term Immune Changes in CLL with Venetoclax Plus Rituximab: MURANO Trial Mar 07, 2023
CML (Chronic Myeloid Leukemia),Leukemia Asciminib Outperforms Bosutinib in Long-Term CML-CP Treatment Feb 27, 2023
CLL (Chronic Lymphocytic Leukemia),Leukemia CLL14 Study: Cost-Effectiveness of VenO vs. ClbO Feb 27, 2023
ALL (Acute Lymphoblastic Leukemia),Leukemia Improved Outcomes in High-Risk Relapsed B-ALL with Blinatumomab Feb 27, 2023
